Clinical trial
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of…
NCT00032669 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00032669 |
|---|---|
| Title | Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children |
| Official title | Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | HAART |
| Enrollment | 34 |
| Start date | Mar 1, 2002 |
| Completion | Apr 1, 2006 |
| First posted | Mar 28, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: